BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24967418)

  • 1. Prolonged nitric oxide exposure enhances anoikis resistance and migration through epithelial-mesenchymal transition and caveolin-1 upregulation.
    Chanvorachote P; Pongrakhananon V; Chunhacha P
    Biomed Res Int; 2014; 2014():941359. PubMed ID: 24967418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.
    Busaranon K; Plaimee P; Sritularak B; Chanvorachote P
    J Nat Med; 2016 Jan; 70(1):18-27. PubMed ID: 26384689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells.
    Yongsanguanchai N; Pongrakhananon V; Mutirangura A; Rojanasakul Y; Chanvorachote P
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C89-100. PubMed ID: 25411331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1.
    Chanvorachote P; Nimmannit U; Lu Y; Talbott S; Jiang BH; Rojanasakul Y
    J Biol Chem; 2009 Oct; 284(41):28476-28484. PubMed ID: 19706615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition.
    Phiboonchaiyanan PP; Busaranon K; Ninsontia C; Chanvorachote P
    Cell Biol Toxicol; 2017 Jun; 33(3):251-261. PubMed ID: 27796700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
    Ko H
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
    Unahabhokha T; Chanvorachote P; Pongrakhananon V
    Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells.
    Chanvorachote P; Pongrakhananon V; Halim H
    Mol Cell Biochem; 2015 Jan; 399(1-2):291-302. PubMed ID: 25351339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
    Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
    PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide mediates cell aggregation and mesenchymal to epithelial transition in anoikis-resistant lung cancer cells.
    Powan P; Chanvorachote P
    Mol Cell Biochem; 2014 Aug; 393(1-2):237-45. PubMed ID: 24771070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triclosan potentiates epithelial-to-mesenchymal transition in anoikis-resistant human lung cancer cells.
    Winitthana T; Lawanprasert S; Chanvorachote P
    PLoS One; 2014; 9(10):e110851. PubMed ID: 25329306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
    Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
    Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
    Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition.
    Kannan A; Krishnan A; Ali M; Subramaniam S; Halagowder D; Sivasithamparam ND
    Eur J Cancer; 2014 Jan; 50(1):204-15. PubMed ID: 24070739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.